Advanced search
Publication Cover
mAbs Volume 15, 2023 - Issue 1
Submit an article Journal homepage
2,314
Views
1
CrossRef citations to date
0
Altmetric
Report

A novel anti-NGF PEGylated Fab’ provides analgesia with lower risk of adverse effects

Yukari Koyaa Drug Discovery Research, Astellas Pharma Inc, Tsukuba, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3103-7271View further author information
ORCID Icon,
Hirotsugu Tanakab Incubation Lab, Astellas Innovation Management LLC, Cambridge, MA, USAView further author information
,
Eiji Yoshimia Drug Discovery Research, Astellas Pharma Inc, Tsukuba, JapanView further author information
,
Nobuaki Takeshitaa Drug Discovery Research, Astellas Pharma Inc, Tsukuba, JapanView further author information
,
Shuji Moritaa Drug Discovery Research, Astellas Pharma Inc, Tsukuba, JapanView further author information
,
Hiroki Morioa Drug Discovery Research, Astellas Pharma Inc, Tsukuba, JapanView further author information
,
Kanako Moria Drug Discovery Research, Astellas Pharma Inc, Tsukuba, JapanView further author information
,
Hiroshi Fushikia Drug Discovery Research, Astellas Pharma Inc, Tsukuba, JapanView further author information
&
Masazumi Kamoharaa Drug Discovery Research, Astellas Pharma Inc, Tsukuba, JapanView further author information
 show all
Article: 2149055 | Received 06 Jul 2022, Accepted 15 Nov 2022, Published online: 02 Dec 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.